» Articles » PMID: 28204500

The Patient Costs of Care for Those with TB and HIV: a Cross-sectional Study from South Africa

Overview
Date 2017 Feb 17
PMID 28204500
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study describes the post-diagnosis care-seeking costs incurred by people living with TB and/or HIV and their households, in order to identify the potential benefits of integrated care.

Methods: We conducted a cross-sectional study with 454 participants with TB or HIV or both in public primary health care clinics in Ekurhuleni North Sub-District, South Africa. We collected information on visits to health facilities, direct and indirect costs for participants and for their guardians and caregivers. We define 'integration' as receipt of both TB and HIV services at the same facility, on the same day. Costs were presented and compared across participants with TB/HIV, TB-only and HIV-only. Costs exceeding 10% of participant income were considered catastrophic.

Results: Participants with both TB and HIV faced a greater economic burden (US$74/month) than those with TB-only (US$68/month) or HIV-only (US$40/month). On average, people with TB/HIV made 18.4 visits to health facilities, more than TB-only participants or HIV-only participants who made 16 and 5.1 visits, respectively. However, people with TB/HIV had fewer standalone TB (10.9) and HIV (2.2) visits than those with TB-only (14.5) or HIV-only (4.4). Although people with TB/HIV had access to 'integrated' services, their time loss was substantially higher than for other participants. Overall, 55% of participants encountered catastrophic costs. Access to official social protection schemes was minimal.

Conclusions: People with TB/HIV in South Africa are at high risk of catastrophic costs. To some extent, integration of services reduces the number of standalone TB and HIV of visits to the health facility. It is however unlikely that catastrophic costs can be averted by service integration alone. Our results point to the need for timely social protection, particularly for HIV-positive people starting TB treatment.

Citing Articles

Health and economic impacts of Vaccae vaccination incorporating active case finding in India and South Africa: a modelling study.

Yue W, Zhai P, Mao J, Ma J, Ren W, Jiang T BMJ Public Health. 2025; 2(2):e001042.

PMID: 40018595 PMC: 11816706. DOI: 10.1136/bmjph-2024-001042.


Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.

Evans D, Hirasen K, Ramushu C, Long L, Sinanovic E, Conradie F PLoS One. 2024; 19(10):e0309034.

PMID: 39432463 PMC: 11493257. DOI: 10.1371/journal.pone.0309034.


Psychosocial experiences of adolescents with tuberculosis in Cape Town.

Wademan D, Mlomzale M, Marthinus A, Jacobs S, Mcimeli K, Zimri K PLOS Glob Public Health. 2024; 4(9):e0003539.

PMID: 39302922 PMC: 11414892. DOI: 10.1371/journal.pgph.0003539.


Cross-sectional study of the burden and determinants of non-medical and opportunity costs of accessing chronic disease care in rural Tanzania.

Verjans A, Hooley B, Tani K, Mhalu G, Tediosi F BMJ Open. 2024; 14(3):e080466.

PMID: 38553069 PMC: 10982752. DOI: 10.1136/bmjopen-2023-080466.


Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.

Yamanaka T, Castro M, Ferrer J, Solon J, Cox S, Laurence Y PLoS One. 2024; 19(1):e0297342.

PMID: 38271328 PMC: 10810501. DOI: 10.1371/journal.pone.0297342.


References
1.
Foster N, Vassall A, Cleary S, Cunnama L, Churchyard G, Sinanovic E . The economic burden of TB diagnosis and treatment in South Africa. Soc Sci Med. 2015; 130:42-50. DOI: 10.1016/j.socscimed.2015.01.046. View

2.
Alam K, Mahal A . Economic impacts of health shocks on households in low and middle income countries: a review of the literature. Global Health. 2014; 10:21. PMC: 4108100. DOI: 10.1186/1744-8603-10-21. View

3.
Kaplan R, Caldwell J, Bekker L, Jennings K, Lombard C, Enarson D . Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa. S Afr Med J. 2014; 104(3):204-9. DOI: 10.7196/samj.7696. View

4.
Ledibane T, Motlhanke S, Rose A, Kruger W, Ledibane N, Claassens M . Antiretroviral treatment among co-infected tuberculosis patients in integrated and non-integrated facilities. Public Health Action. 2015; 5(2):112-5. PMC: 4487489. DOI: 10.5588/pha.14.0099. View

5.
Chuma J, Gilson L, Molyneux C . Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health. 2007; 12(5):673-86. DOI: 10.1111/j.1365-3156.2007.01825.x. View